Literature DB >> 10571735

Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators.

K Hanley1, L G Kömüves, N M Bass, S S He, Y Jiang, D Crumrine, R Appel, M Friedman, J Bettencourt, K Min, P M Elias, M L Williams, K R Feingold.   

Abstract

Nuclear receptors which interact with the retinoid X receptor are involved in the regulation of epidermal differentiation and development. We have recently shown that activators of the peroxisome proliferator-activated receptor and of the farnesoid X-activated receptor accelerate epidermal barrier maturation in fetal rat skin in vitro. In this study we asked whether cutaneous development in utero was affected by peroxisome proliferator-activated receptor or farnesoid X-activated receptor activators, or by an activator of another retinoid X receptor partner, liver X receptor. Activators of the peroxisome proliferator-activated receptor (clofibrate or linoleic acid), farnesoid X-activated receptor (farnesol or juvenile hormone III), or liver X receptor (22R-hydroxycholesterol), were injected into the amniotic fluid of fetal rats on gestational day 17. Fetal epidermal barrier function and morphology was assessed on day 19. Whereas vehicle-treated fetal rats displayed no measurable barrier (transepidermal water loss > 10 mg per cm2 per h), a measurable barrier was induced by the intra-amniotic administration of all activators tested (transepidermal water loss range 4.0-8.5 mg per cm2 per h). By light microscopy, control pups lacked a well-defined stratum corneum, whereas a distinct stratum corneum and a thickened stratum granulosum were present in treated pups. By electron microscopy, the extracellular spaces of the stratum corneum in control pups revealed a paucity of mature lamellar unit structures, whereas these structures filled the stratum corneum interstices in treated pups. Additionally, protein and mRNA levels of loricrin and filaggrin, two structural proteins of stratum corneum, were increased in treated epidermis, as were the activities of two lipid catabolic enzymes critical to stratum corneum function, beta-glucocerebrosidase and steroid sulfatase. Finally, peroxisome proliferator-activated receptor-alpha and -delta and liver X receptor-alpha and -beta mRNAs were detected in fetal epidermis by reverse transcriptase-polymerase chain reaction and northern analyses. The presence of these receptors and the ability of their activators to stimulate epidermal barrier and stratum corneum development suggest a physiologic role for peroxisome proliferator-activated receptor and liver X receptor and their endogenous ligands in the regulation of cutaneous development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571735     DOI: 10.1046/j.1523-1747.1999.00743.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  PPAR-alpha in cutaneous inflammation.

Authors:  Sandrine Dubrac; Matthias Schmuth
Journal:  Dermatoendocrinol       Date:  2011-01

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.

Authors:  Carrie Hayes Sutter; Sridevi Bodreddigari; Christina Campion; Ryan S Wible; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2011-08-11       Impact factor: 4.849

3.  Differentiation of the sebaceous gland.

Authors:  Catherin Niemann
Journal:  Dermatoendocrinol       Date:  2009-03

Review 4.  Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.

Authors:  Nicolas Di-Poï; Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

5.  Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin.

Authors:  Sujong Kim; Il Hong; Jung Sun Hwang; Jin Kyu Choi; Ho Sik Rho; Duck Hee Kim; Ihseop Chang; Seung Hun Lee; Mi-Ock Lee; Jae Sung Hwang
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

6.  PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis.

Authors:  Yan J Jiang; Peggy Kim; Yang F Lu; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2011-04-04       Impact factor: 3.960

7.  Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice.

Authors:  Qian Yang; Reiko Kurotani; Atsushi Yamada; Shioko Kimura; Frank J Gonzalez
Journal:  Endocrinology       Date:  2006-07-20       Impact factor: 4.736

Review 8.  Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?

Authors:  Günther Weindl; Monika Schäfer-Korting; Martin Schaller; Hans Christian Korting
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.

Authors:  Joachim W Fluhr; Mao-Qiang Man; Jean-Pierre Hachem; Debra Crumrine; Theodora M Mauro; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

Review 10.  Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes.

Authors:  Kelvin Yin; Aaron G Smith
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.